These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15871897)

  • 1. Updated National Cholesterol Education Program III guidelines.
    Aronow WS
    J Am Med Dir Assoc; 2005; 6(2):160-1. PubMed ID: 15871897
    [No Abstract]   [Full Text] [Related]  

  • 2. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.
    Stone NJ; Bilek S; Rosenbaum S
    Am J Cardiol; 2005 Aug; 96(4A):53E-59E. PubMed ID: 16098845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol guidelines update: more aggressive therapy for higher-risk patients.
    Huang JC; Hoogwerf BJ
    Cleve Clin J Med; 2005 Mar; 72(3):253-62. PubMed ID: 15825805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Don't trust an LDL over 70?
    Aronow WS
    Geriatrics; 2004 May; 59(5):12-3. PubMed ID: 15152729
    [No Abstract]   [Full Text] [Related]  

  • 8. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract]   [Full Text] [Related]  

  • 9. The primary target. Taking aim at LDL levels to prevent cardiovascular disease.
    Mason CM
    Adv Nurse Pract; 2007 Dec; 15(12):55-8. PubMed ID: 20014676
    [No Abstract]   [Full Text] [Related]  

  • 10. Achieving lipid goals. A study of outcomes in an NP Clinic.
    Adkins J; Stanley M
    Adv Nurse Pract; 2007 Jun; 15(6):61-2, 64. PubMed ID: 19999011
    [No Abstract]   [Full Text] [Related]  

  • 11. Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):591-2. PubMed ID: 15972605
    [No Abstract]   [Full Text] [Related]  

  • 12. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Cholesterol and the aged: ...and the beat goes on.
    Wilson MM
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):600-2; author reply 602. PubMed ID: 15972610
    [No Abstract]   [Full Text] [Related]  

  • 13. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary.
    Levy DR; Pearson TA
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):597-8; author reply 602. PubMed ID: 16094772
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical decisions. The guidelines battle on starting statins.
    D'Agostino RB; Ansell BJ; Mora S; Krumholz HM
    N Engl J Med; 2014 Apr; 370(17):1652-8. PubMed ID: 24758622
    [No Abstract]   [Full Text] [Related]  

  • 15. Should family physicians follow the new ACC/AHA cholesterol treatment guideline? Not completely: why it is right to drop LDL-C targets but wrong to recommend statins at a 7.5% 10-year risk.
    Hayward RA
    Am Fam Physician; 2014 Aug; 90(4):223-4. PubMed ID: 25250995
    [No Abstract]   [Full Text] [Related]  

  • 16. An update to the National Cholesterol Education Program: 2009 suggested changes.
    Medina-Ruíz A
    Bol Asoc Med P R; 2009; 101(4):30-3. PubMed ID: 20853557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.
    Mann D; Reynolds K; Smith D; Muntner P
    Ann Pharmacother; 2008 Sep; 42(9):1208-15. PubMed ID: 18648016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCEP's new guidelines at a glance. National Cholesterol Education Program.
    Benedict M
    Health Care Food Nutr Focus; 2002 Aug; 18(12):8-9. PubMed ID: 12192777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.